Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 17.49 -0.33 (-1.85%) Market Cap: 472.97 Mil Enterprise Value: 251.50 Mil PE Ratio: 0 PB Ratio: 1.83 GF Score: 74/100

Q4 2019 Arcturus Therapeutics Holdings Inc Earnings Call Transcript

Mar 11, 2020 / 08:30PM GMT
Release Date Price: $13.09 (-3.32%)
Operator

Greetings. Welcome to the Arcturus Therapeutics Fourth Quarter and Fiscal Year 2019 Earnings Call. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, Neda Safarzadeh, Director, Head of Investor Relations. Please go ahead.

Neda Safarzadeh;Public Relations;Marketing
Arcturus Therapeutics Holdings Inc. - Director and Head of IR

/&

Thank you, operator, and good afternoon, everyone. Thank you for joining Arcturus' earnings conference call. We are excited for this opportunity to discuss the company's fourth quarter and year-end 2019 operating results and certain recent developments. We are joined today by Joseph Payne, President and CEO; and Andy Sassine, CFO. Dr. Pad Chivukula, CSO and COO, is also on the line and will be available to address questions during the Q&A session.

Joe will kick off the call with a high-level review of Arcturus. Next, Andy will discuss the fourth quarter financial results and recap certain recent developments

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot